Eaton Vance Management Novavax Inc Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $31,378 - $64,305	-450 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $16,685 - $27,028	124 Added 38.04%	450 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $177 - $270	1 Added 0.31%	326 $0
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $6,050 - $12,883	50 Added 18.18%	325 $69,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $31,069 - $87,980	275 New	275 $50,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.